Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Healthcare

Telix Pharmaceuticals (ASX:TLX): Targeted Radiation Platform Expands with New Imaging Milestone

Telix Pharmaceuticals Limited (ASX:TLX) is a biotechnology company focused on radiopharmaceuticals used in precision medicine. The company develops products that combine radioactive isotopes with targeting molecules to support cancer imaging and potential therapeutic applications.

Sonal Goyal | 18 September 2026

Invex Therapeutics (ASX:IXC): Strategic Reset Follows Closure of Flagship Brain-Pressure Trial

Invex Therapeutics Ltd (ASX:IXC) is a biotechnology company focused on developing treatments for neurological conditions involving elevated intracranial pressure. The company’s development pathway changed after the closure of its lead clinical trial, placing future strategy andCapitalmanagement at the centre of its current position.

Sonal Goyal | 18 September 2026

BPH Global (ASX:BP8): Seaweed Strategy Expands into Men’s Health Product Development

BPH Global Ltd (ASX:BP8) is a company involved in seaweed-related activities, including trading operations in Indonesia and exploration of seaweed-derived consumer health products. The company's current strategy combines an operating business with early-stage product development initiatives.

Sonal Goyal | 18 September 2026

Paradigm Biopharmaceuticals (ASX:PAR): Phase 3 Osteoarthritis Trial Becomes Key Development Milestone

Paradigm Biopharmaceuticals Ltd (ASX:PAR) is a biotechnology company developing therapies based on pentosan polysulfate sodium. The company’s current focus is advancing Zilosul through clinical development for osteoarthritis, with its Phase 3 trial representing a major stage in the programme.

Sonal Goyal | 18 September 2026

Rhythm Biosciences (ASX:RHY): Blood Test Development Shapes the Next Phase of ColoSTAT

Rhythm Biosciences Limited (ASX:RHY) is an Australian medical diagnostics company developing technologies aimed at improving cancer detection. The company’s lead product, ColoSTAT, is being developed as a blood-based assessment tool for colorectal cancer risk, with commercialisation and regulatory progress forming key parts of its …

Sonal Goyal | 18 September 2026

LTR Pharma (ASX:LTP): Nasal Spray Drug Delivery Approach Targets Erectile Dysfunction Market

LTR Pharma Limited (ASX:LTP) is a clinical-stage pharmaceutical company focused on developing nasal spray drug delivery technologies. The company’s lead product, SPONTAN in Australia and ROXUS in the United States, is designed to deliver an established erectile dysfunction medicine through the nasal route. This …

Sonal Goyal | 18 September 2026

Noxopharm (ASX:NOX): Immune System Targeting Shapes Biotechnology Development Strategy

Noxopharm Limited (ASX:NOX) is an Australian clinical-stage biotechnology company developing therapies based on immune system modulation. The company’s Sofra platform uses synthetic oligonucleotides designed to influence innate immune responses, while its Chroma platform focuses on oncology applications. This article examines Noxopharm’s technology platforms and …

Sonal Goyal | 18 September 2026

EMVision Medical Devices (ASX:EMV): Portable Brain Imaging Technology Targets Stroke Care

EMVision Medical Devices Ltd (ASX:EMV) is an Australian medical technology company developing portable brain imaging systems. The company’s technology aims to support faster assessment of stroke patients by bringing imaging capability closer to the point of care, including hospitals and potentially ambulances. This article …

Sonal Goyal | 18 September 2026

CONNEQT Health (ASX:CQT): Beyond Blood Pressure Monitoring with Cardiovascular Technology

CONNEQT Health Limited (ASX:CQT) is an Australian cardiovascular technology company focused on developing connected health solutions. Formerly known as CardieX, the company uses its SphygmoCor technology platform to provide advanced cardiovascular measurements through connected devices. This article examines how CONNEQT is expanding beyond traditional …

Sonal Goyal | 18 September 2026

Compumedics (ASX:CMP): Sleep Diagnostics and Software Expansion Shape Growth Strategy

Compumedics Limited (ASX:CMP) is an Australian medical technology company focused on sleep diagnostics, neurological monitoring and healthcare software solutions. The company develops systems used by healthcare providers to diagnose and monitor conditions affecting sleep and brain function. This article examines how Compumedics is expanding …

Sonal Goyal | 18 September 2026
Support

Hi! How can we help you today?

Loading…